Product image of Glucose-Infusionslösung 5 (Glucose Monohydrate) supplied by GNH India

Glucose-Infusionslösung 5

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glucose-Infusionslösung 5 (Glucose Monohydrate)

Glucose-Infusionslösung 5 is an intravenous solution for injection that contains glucose monohydrate as the sole active ingredient. It is supplied in a sterile liquid form and is marketed within the European Union. The preparation is used to provide an immediate source of carbohydrate and calories when administered directly into the bloodstream.

Manufacturer / TM Owner

Burg Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose-Infusionslösung 5 is employed in clinical settings where rapid elevation of plasma glucose is required. Typical applications include:

  • Treatment of hypoglycaemia in patients unable to take oral glucose.
  • Provision of caloric support during peri‑operative fasting.
  • Maintenance of blood glucose levels in critically ill or trauma patients.
  • Use as a carrier for compatible intravenous medications.
  • Support during parenteral nutrition regimens when carbohydrate supplementation is needed.

Side Effects

Adverse reactions to Glucose-Infusionslösung 5 are generally related to the infusion process and the glucose load. They are categorized as follows:

Common

  • Local irritation or pain at the infusion site.
  • Mild hyperglycaemia when administered in excess.
  • Nausea or vomiting secondary to rapid glucose infusion.
  • Electrolyte shifts, particularly low potassium levels.

Serious

  • Severe hyperglycaemia leading to osmotic diuresis.
  • Fluid overload or pulmonary oedema in patients with compromised cardiac function.
  • Hyperosmolar hyperglycaemic state in susceptible individuals.
  • Allergic reactions such as urticaria or anaphylaxis, though rare.

Precautions & Warnings

When using Glucose-Infusionslösung 5, clinicians should observe several safety measures. Important considerations include:

  • Assess baseline blood glucose and monitor levels frequently during infusion.
  • Adjust infusion rates in patients with renal or cardiac insufficiency to avoid fluid overload.
  • Use caution in diabetic patients to prevent excessive hyperglycaemia.
  • Verify compatibility with other intravenous solutions before co‑administration.
  • Ensure aseptic technique to reduce risk of infection at the infusion site.
  • Review patient history for known hypersensitivity to glucose solutions.

Avoid Interactions

Glucose-Infusionslösung 5 may interact with other agents administered intravenously. Interactions are grouped as follows:

Avoid

  • Co‑administration with high‑dose insulin without close glucose monitoring.
  • Simultaneous infusion of potassium chloride solutions, which can exacerbate hyperkalemia.

Use with caution

  • Concurrent use of diuretics that may alter electrolyte balance.
  • Administration alongside other hyperosmolar solutions, which can increase risk of fluid shifts.
  • Use with catecholamines that may affect glucose metabolism.
  • Combination with glucocorticoids, which can raise blood glucose levels.

Frequently Asked Questions

The solution is used to quickly increase plasma glucose levels and supply calories when administered intravenously, especially in patients who cannot take oral carbohydrates.

It is given as a sterile solution for injection directly into a vein, following aseptic technique and appropriate infusion rate calculations.

Yes, but blood glucose should be closely monitored and infusion rates adjusted to avoid excessive hyperglycaemia.

Frequent checks of blood glucose, electrolytes, and fluid balance are recommended, especially in patients with renal or cardiac disease.

Compatibility should be verified for each medication; some drugs may precipitate or cause instability when mixed with glucose solutions.

Common effects include mild hyperglycaemia, local irritation at the infusion site, nausea, and transient electrolyte changes.

It should be avoided in patients with known hypersensitivity to glucose solutions or in situations where rapid fluid overload could be hazardous.

The intravenous route bypasses gastrointestinal absorption, providing an immediate rise in blood glucose, whereas oral tablets depend on digestive uptake.

The ATC classification is B05BA01, indicating it is a blood substitute and perfusion solution containing glucose.

Use in children is possible but requires dose adjustment and careful monitoring by a pediatric specialist.

Infusion rates should be limited, and fluid status closely monitored to prevent pulmonary oedema or worsening heart failure.

The risk is low when proper aseptic technique is used, but any intravenous line carries a potential infection risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.